Skip to main content
05/08/2024 - 16:03

Radiopharm banks US$2m in sales to American medical giant

05/08/2024 - 16:03

Bookmark

Save articles for future reference.

Radiopharm Theranostics has banked US$2 million from American medical giant Lantheus for the sale of two preclinical antibody assets that target and help to diagnose aggressive cancers. Lantheus is also set to tip in a further US$5 million via a placement at 5c a share – a 42 per cent premium to today’s price – with an option for another US$5 million investment within six months.

X